Dld Asset Management, LP Relmada Therapeutics, Inc. Put Options Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $1.44 Million - $2.65 Million	87,400 New	87,400 $1.66 Million
Q3 2021 Nov 12, 2021	SELL	$21.86 - $34.77 $668,916 - $1.06 Million	-30,600 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$29.55 - $39.15 $904,230 - $1.2 Million	30,600 New	30,600 $978,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $77.8M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.